Mark D. Lindner
6Patents
6h-index
5Co-inventors
45Inventor score
Filing activity: May 25, 1995 → Jan 25, 1999
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5639275A | Delivery of biologically active molecules using cells contained in biocompatible immunoisolatory capsules | Human Necessities | 137 | Expired |
| US5653975A | Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules | Human Necessities | 82 | Expired |
| US5656481A | Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules | Human Necessities | 64 | Expired |
| US5676943A | Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules | Human Necessities | 56 | Expired |
| US5908623A | Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules | Human Necessities | 26 | Expired |
| US6264941A | Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules | Human Necessities | 12 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.